SU1106444A3 - Способ получени замещенных дибензооксепинов или их солей или оптических изомеров - Google Patents

Способ получени замещенных дибензооксепинов или их солей или оптических изомеров

Info

Publication number
SU1106444A3
SU1106444A3 SU813269597A SU3269597A SU1106444A3 SU 1106444 A3 SU1106444 A3 SU 1106444A3 SU 813269597 A SU813269597 A SU 813269597A SU 3269597 A SU3269597 A SU 3269597A SU 1106444 A3 SU1106444 A3 SU 1106444A3
Authority
SU
USSR - Soviet Union
Prior art keywords
dibenzo
dioxepin
chloro
general formula
ethylamine
Prior art date
Application number
SU813269597A
Other languages
English (en)
Russian (ru)
Inventor
Мален Шарль
Пуанян Жан-Клод
Original Assignee
Сьянс Юньон Э Ко (Фирма)
Сосьете Франсэз Де Решерш Медикаль (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сьянс Юньон Э Ко (Фирма), Сосьете Франсэз Де Решерш Медикаль (Фирма) filed Critical Сьянс Юньон Э Ко (Фирма)
Application granted granted Critical
Publication of SU1106444A3 publication Critical patent/SU1106444A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU813269597A 1980-04-10 1981-04-09 Способ получени замещенных дибензооксепинов или их солей или оптических изомеров SU1106444A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8008023A FR2480283A1 (fr) 1980-04-10 1980-04-10 Nouveaux derives tricycliques, leurs procedes de preparation et leur utilisation comme medicament

Publications (1)

Publication Number Publication Date
SU1106444A3 true SU1106444A3 (ru) 1984-07-30

Family

ID=9240699

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813269597A SU1106444A3 (ru) 1980-04-10 1981-04-09 Способ получени замещенных дибензооксепинов или их солей или оптических изомеров

Country Status (23)

Country Link
US (1) US4459306A (enExample)
EP (1) EP0041410B1 (enExample)
JP (1) JPS56158780A (enExample)
AR (1) AR229026A1 (enExample)
AT (1) ATE5257T1 (enExample)
AU (1) AU538054B2 (enExample)
CA (1) CA1181068A (enExample)
DD (1) DD158242A5 (enExample)
DE (1) DE3161358D1 (enExample)
DK (1) DK159981A (enExample)
ES (2) ES8306483A1 (enExample)
FI (1) FI811059L (enExample)
FR (1) FR2480283A1 (enExample)
GR (1) GR75194B (enExample)
IL (1) IL62622A (enExample)
MA (1) MA19113A1 (enExample)
NO (1) NO811229L (enExample)
NZ (1) NZ196774A (enExample)
OA (1) OA06779A (enExample)
PT (1) PT72833B (enExample)
SU (1) SU1106444A3 (enExample)
YU (1) YU92481A (enExample)
ZA (1) ZA812379B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
CA1208653A (en) * 1982-09-30 1986-07-29 Pierre Hamel 6h-dibenz [b,e] [1,4] oxathiepin derivatives
BR9506924A (pt) * 1994-03-02 1997-09-30 Akzo Nobel Nv Composição farmacêutica sublingual ou bucal e utilização do trans-5-cloro-2-metil-2,3,3a, 12b-tetraidro-1h-dibenz(2,3:6,7) oxepino(4,5-c)pirrol
JP4006796B2 (ja) 1997-11-17 2007-11-14 株式会社日立製作所 個人情報管理方法および装置
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
US20110305751A1 (en) 2009-02-20 2011-12-15 To-Bbb Holding B.V. Glutathione-based drug delivery system
AU2010245823B2 (en) 2009-05-06 2016-11-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111377901A (zh) * 2018-12-27 2020-07-07 华东理工大学 一种缩酚酸环醚类化合物及其制备方法与用途
AU2022253074A1 (en) * 2021-04-10 2023-10-12 Sunovion Pharmaceuticals Inc. Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312891A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux 1.5-benzo-dioxépannes et leur préparation
ES274336A1 (es) * 1961-01-30 1962-06-01 Geigy Ag J R Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
FR1312889A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux benzo-dioxépannes et leur préparation
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
US3821249A (en) * 1970-03-13 1974-06-28 En Nom Collectif Science Union Dibenzothiazefin derivatives
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4335122A (en) * 1981-03-18 1982-06-15 Hoechst-Roussel Pharmaceuticals Inc. Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Гетероциклические соединени . Под ред. Эльдерфилда. М., ИЛ, 1954, с. 6-16. 2.Вейганд-Хильгетаг. Методы эксперимента в органической химии. М., Хими , 1968, с. 22-52. 3.Гейлорд Н. Восстановление комплексными гидридами металлов. М., ИЛ, 1959, с. 340-447. 4.Бюлер К., Пирсон Д. Органические синтезы. М., Мир, 1973, ч. 1, с. 374г384. 5.Там же, с. 504-511. *

Also Published As

Publication number Publication date
ES500942A0 (es) 1983-06-01
IL62622A (en) 1984-10-31
FR2480283B1 (enExample) 1983-09-23
US4459306A (en) 1984-07-10
JPS6116394B2 (enExample) 1986-04-30
ZA812379B (en) 1982-04-28
FI811059A7 (fi) 1981-10-11
AU538054B2 (en) 1984-07-26
NZ196774A (en) 1983-09-30
IL62622A0 (en) 1981-06-29
DK159981A (da) 1981-10-11
AR229026A1 (es) 1983-05-31
FI811059L (fi) 1981-10-11
MA19113A1 (fr) 1981-12-31
ES8400742A1 (es) 1983-11-16
OA06779A (fr) 1982-12-31
PT72833A (fr) 1981-05-01
YU92481A (en) 1984-02-29
AU6934081A (en) 1981-10-15
NO811229L (no) 1981-10-12
EP0041410A1 (fr) 1981-12-09
DD158242A5 (de) 1983-01-05
DE3161358D1 (en) 1983-12-15
ATE5257T1 (de) 1983-11-15
CA1181068A (fr) 1985-01-15
EP0041410B1 (fr) 1983-11-09
PT72833B (fr) 1982-07-26
FR2480283A1 (fr) 1981-10-16
ES519463A0 (es) 1983-11-16
GR75194B (enExample) 1984-07-13
JPS56158780A (en) 1981-12-07
ES8306483A1 (es) 1983-06-01

Similar Documents

Publication Publication Date Title
SU1106444A3 (ru) Способ получени замещенных дибензооксепинов или их солей или оптических изомеров
EP0074304A1 (fr) Ethers tricycliques, leur préparation et les compositions pharmaceutiques les contenant
DE69211994T2 (de) Lignan-analoge, ihre herstellung und hypolipidemische arzneimittel
US4886835A (en) Alkadiene derivatives, their preparation, and pharmaceutical compositions containing them
US4596821A (en) Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4604403A (en) Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4634717A (en) Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
EP0257921A2 (en) New 1,3-diaryl cyclopentanes and derivatives thereof as paf antagonists
CH655100A5 (fr) 1-cyclohexenyl-2-(hydroxy- ou chloro-)ethyl-pyrrolidine et procede pour sa preparation.
CH635573A5 (en) Process for preparing novel 1,2-dihydroxypropane derivatives
FI61310C (fi) Nytt foerfarande foer framstaellning av saosom ett laekemedel anvaendbar 5-metyl-1-fenyl-1,3,4,6-tetrahydro-5h-bens(f)-2,5-oxazocin
PL102604B1 (pl) Sposob wytwarzania fluoropochodnych kwasow alkanokarboksylowych
US5008411A (en) Glycidic acid ester and process of preparation
EP0198762B1 (fr) Dérivés d'acide dibenzo[be]oxépinne-acétique, leur préparation, et des médicaments les contenant
CH646694A5 (fr) Derives de la 3,4,5-trimethoxy cinnamoyle piperazine et leur procede de preparation.
CH628034A5 (en) Process for the preparation of new benzo[c]quinol-9-(8H)-ones
US5246966A (en) Substituted alkenoic acid and its derivatives
SU884568A3 (ru) Способ получени (арилалкил) алкановых кислот
US20080249312A1 (en) Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine
NO139438B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive seco-prostaglandiner
CH683340A5 (de) Verfahren zur Herstellung von 2,2-Dimethyl-5-(2,5-Dimethylphenoxy)-Pentansäure.
FR2649981A1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
CA1197511A (fr) Haloalkyl-8-4h-¬1|-benzopyran-4-ones, et procede de preparation
US4537979A (en) Alpha-substituted-alkylarylketals particularly useful for preparing alpha-arylalkanoic acids
JP3047582B2 (ja) トレオ−4−アルコキシ−5−(アリールヒドロキシメチル)−2(5h)−フラノンの製造方法